Latest Market News

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Eclipse Metals has engaged BGR Group, a leading U.S. government relations firm, to strengthen its strategic positioning and funding prospects for its Greenland rare earth projects, advancing its role in Western critical minerals supply chains.

Alma Metals Limited has announced a Share Purchase Plan offering eligible Australian and New Zealand shareholders the chance to buy new shares at a 15% discount, aiming to bolster its capital base ahead of year-end.

Patriot Resources has expanded the mineralised footprint at its Kitumba Project in Zambia, doubling the strike length of its key copper-zinc-lead target through advanced geophysical surveys.

Enlitic has expanded its collaboration with GE Healthcare, adding around US$1 million in revenue and broadening the use of its medical imaging data solutions. This move underscores growing trust and integration between the two companies.

CZR Resources has launched its first major drilling campaign in five years at the Top Camp prospect within the Croydon Gold Project, aiming to extend high-grade gold zones and explore Hemi-style intrusions.

Whitefield Income Limited has successfully completed a $52.9 million placement to wholesale investors, issuing over 40 million new shares amid strong demand. The capital raise leverages the company’s full placement capacity without requiring shareholder approval.

Lion Rock Minerals has kicked off a large-scale infill drilling program at its Minta Est project in Cameroon, focusing on high-value minerals including rutile, zircon, and rare-earth elements monazite and xenotime. This move builds on recent discoveries and a strategic partnership with Tronox Holdings.

Axel REE Limited reports promising metallurgical results from its Caladão Project in Brazil, confirming a magnet-rich ionic clay system with rare earth grades comparable to established Asian operations. These findings underpin a low-capital, low-operating cost in-situ leach development strategy.

Blue Star Helium reports substantial progress on its Galactica helium facility, maintaining its target for first production in December 2025. Key construction and equipment milestones have been achieved, signaling a critical phase in the project’s development.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.